3.130USD-0.16%Mkt Cap: 805.76M USDP/E: InfinityLast update: 2026-06-01
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's …
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap805.76M USD
Enterprise Value1.19B USD
Revenue (TTM)418.24M USD
Gross Profit273.91M USD
Net Income (TTM)-22.68M USD
Revenue/Share1.887 USD
Last Price3.130 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees294
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS29664W1053
Valuation
P/E (Trailing)Infinity
P/E (Forward)10.72
PEG—
EV/EBITDA15.72
EV/Revenue2.85
P/S1.93
P/B-2.54
EPS (TTM)0.00
EPS (Forward)0.29
52W Range
0.810069% of range4.180
52W High4.180 USD
52W Low0.8100 USD
Profitability
Gross Margin67.95%
Oper. Margin-8.22%
EBITDA Margin18.15%
Profit Margin-5.63%
ROE7.51%
ROA-4.87%
Growth
Revenue Growth23.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.09M USD
CapEx (TTM)—
FCF Margin-11.88%
FCF Yield-6.17%
Net Debt387.65M USD
Net Debt/EBITDA5.11
Balance Sheet
Debt/Equity-0.84
Current Ratio1.53
Quick Ratio0.96
Book Value/Sh-1.2310 USD
Cash/Share0.6070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.190 USD
Target Range3.160 USD – 3.280 USD
# Analysts4
Ownership
Shares Out.257.43M
Float255.18M
Insiders0.68%
Institutions69.78%
Short Interest
Short Ratio1.0d
Short % Float7.97%
Short % Out.7.85%
Shares Short20.21M
Short (prev mo.)31.83M
Technical
SMA 502.616 (+19.6%)
SMA 2002.941 (+6.4%)
Beta0.91
S&P 52W Chg27.94%
Avg Vol (30d)16.71M
Avg Vol (10d)8.49M
Technical Indicators
RSI (14)71.9
MACD0.1598
MACD Signal0.1763
MACD Hist.-0.0165
BB Upper3.146 USD
BB Middle3.128 USD
BB Lower3.111 USD
BB Width1.14%
ATR (14)0.0689 USD
Vol Ratio (20d)0.20x